RESHAPE LIFESCIENCES INC (RSLS)
US76090R2004 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.39M | -46.21M | -61.93M | -12.33M | -23.68M | |||
| Depreciation Amortization | 154.00K | 2.15M | 1.97M | 340.00K | 480.00K | |||
| Income Taxes - Deferred | 28.00K | -420.00K | -60.00K | N/A | N/A | |||
| Change In Working Capital | -8.01M | 710.00K | -2.74M | -1.40M | -3.26M | |||
| Interest Paid | 0.00 | 0.00 | 300.00K | 0.00 | 720.00K | |||
| Taxes Paid | 10.00K | 10.00K | 100.00K | 0.00 | 0.00 | |||
| Other non cash items | 2.26M | 21.87M | 47.39M | 2.99M | 3.59M | |||
| OPERATING CASH FLOW | -16.96M | -21.90M | -15.38M | -10.41M | -22.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -43.00K | -130.00K | -350.00K | -170.00K | -190.00K | |||
| Other Investing Activity | 33.00K | 40.00K | 2.21M | 0.00 | 2.55M | |||
| INVESTING CASH FLOW | -10.00K | -90.00K | 1.86M | -170.00K | 2.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -9.50M | 430.00K | -10.00M | |||
| Stock Issued/Repurchased | 17.57M | 3.13M | 46.03M | 0.00 | 23.38M | |||
| Other Financing Activity | N/A | 0.00 | -3.23M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 17.57M | 3.13M | 33.30M | 430.00K | 13.38M | |||
| Exchange Rate Effect | 0.00 | 0.00 | 30.00K | N/A | N/A | |||
| CHANGE IN CASH | 604.00K | -18.86M | 19.81M | -10.15M | -7.13M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.96M | -21.90M | -15.38M | -10.41M | -22.87M | |||
| Capital Expenditure | -43.00K | -130.00K | -350.00K | -170.00K | -190.00K | |||
| FREE CASH FLOW | -17.00M | -22.03M | -15.73M | -10.58M | -23.06M | |||
All data in USD